A specialty-based community offering cardiologic CME/CE courses, resources, and news, centered on you.
Cardiology Advisor Institute Spotlight Course
Mitral Valve Disease: Role of Transcatheter Intervention for Optimal Lifetime Management
1.00 CME CE: Join three top experts in the field as they discuss the state-of-the-art in mitral valve repair and replacement. Exp 1/13/24
Additional Cardiology Courses
Digital Pathway – Changing the Treatment Paradigm for LDL-C Lowering Post-MI: The Case for Early, ‘High-Intensity Lipid Lowering Therapy’ to Improve Outcomes
1.50 CME CE: Risk of a recurrent CV event post-MI is substantial. Targeted LDL-C optimization of lipid lowering therapy remains suboptimal. Exp 9/23/23
TAVR Update: Underutilization, Clinical Outcomes, Costs, and Future Directions
1.00 CME CE: Many patients who would benefit from transcatheter aortic valve replacement go untreated. Learn about cost-saving TAVR implementation. Exp 9/30/2023
Homozygous Familial Hypercholesterolemia: Improving Outcomes Through Timely Diagnosis and Treatment
1.00 CME CE: Homozygous Familial Hypercholesterolemia is rare, but clinicians in cardiology, primary care, and pediatrics can improve outcomes. Exp 10/31/23
Improving HoFH Outcomes: Strategies for Better Treatment and Reduced Barriers to Care
CME 1.00: Discusses diagnosing and treating HoFH patients and how to improve HoFH patient outcomes and quality of life. Exp 4/14/23
Mechanical Circulatory Support: Right, Left, and Biventricular
1.00 CME: Right-Sided MCS with RA-PA Pump and Left-Sided MCS with LA-AO Pump. Emerging role of VA ECMO in cath lab and biventricular MCS. Exp 5/30/23
Optimizing Antiplatelet Therapy in Cardiogenic Shock
1.00 CME: Pharmacokinetic/pharmacodynamic profile of parenteral antiplatelet agents and future antiplatelet and antithrombotic therapeutic targets. Exp 5/30/23
Better Weight Management, Better Outcomes: Practical Approaches to Managing the Interrelated Conditions of Obesity and PCOS
2.00 CME CE: This program is for clinicians interested in the treatment of PCOS and other women’s health challenges related to excess weight or obesity. 6/27/23
Cardiac Risk Stratification in Action
In the third part of this CME series, faculty will discuss patient cases to assess hs-cTn testing as a prognostic tool for secondary and primary prevention.
Mitral Valve Disease: Role of Transcatheter Intervention for Optimal Lifetime Management
1.00 CME CE: Join three top experts in the field as they discuss the state-of-the-art in mitral valve repair and replacement. Exp 1/13/24
Part 2 of 2: Exploring Perspectives in Obesity Management: From Personal Experience to Best Practice
0.50 CME CE: This podcast will explore personal experiences from a person living with obesity, and what providers can do to overcome stigma associated with the disease. Exp 7/28/23
Digital Pathway – The Evolving Landscape of LDL-C Reduction in High-Risk Patients: Optimizing Combination Therapy to Reduce ASCVD Risk
1.00 CME CE: Experts discuss the efficacy and safety of new approaches of LDL-C lowering therapy and current treatment options’ application to patient care. Exp 11/4/23
Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs
1.00 CME: Learn about the etiology of anemia in CKD, the effects on CV disease, and advantages and limitations of current management strategies. Exp 11/16/23